#ASGCT25: In three patients, Rocket’s second heart gene therapy shows promisenews2025-05-16T15:25:53+00:00May 16th, 2025|Endpoints News|
Eli Lilly teams up with RNA editing biotech for hearing lossnews2025-05-15T17:30:49+00:00May 15th, 2025|Endpoints News|
Philadelphia doctors treat infant with first custom CRISPR therapy that fixes genetic mutationnews2025-05-15T17:00:12+00:00May 15th, 2025|Endpoints News|
Advocacy groups and experts call for decade-long ban on germline editingnews2025-05-14T10:00:09+00:00May 14th, 2025|Endpoints News|
CRISPR patent spat revived by federal appeals court rulingnews2025-05-13T20:05:09+00:00May 13th, 2025|Endpoints News|
Galapagos backpedals on separation plans, CEO Paul Stoffels exits earlynews2025-05-13T11:23:05+00:00May 13th, 2025|Endpoints News|
Exclusive: Patrick Hsu’s startup Stylus Medicine launches, looks beyond CRISPR for gene insertion technews2025-05-12T15:27:02+00:00May 12th, 2025|Endpoints News|
CRISPR isn’t living up to its potential. Two scientists have a plan to fix thatnews2025-05-08T14:00:20+00:00May 8th, 2025|Endpoints News|
CRISPR Therapeutics’ gene editing therapy reduces bad cholesterol and triglycerides by as much as 80%news2025-05-07T11:00:16+00:00May 7th, 2025|Endpoints News|
Singapore cardio gene therapy biotech collects $45M as it plots Europe expansionnews2025-05-06T05:00:34+00:00May 6th, 2025|Endpoints News|
